MAIA BIOTECHNOLOGY INC's ticker is and the CUSIP is 552641102. A total of 7 filers reported holding MAIA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,000 | – | 10,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 35,000 | $77,000 | 0.10% |
| Centric Wealth Management | 64,456 | $142,448 | 0.06% |
| Naviter Wealth, LLC | 22,168 | $48,770 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,600 | $58,520 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $75 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 33,987 | $74,771 | 0.00% |
| BlackRock Inc. | 8,017 | $17,638 | 0.00% |
| Citadel Advisors | 23,387 | $51,451 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,962 | $8,716 | 0.00% |